Research community protocols for subcutaneous use commonly start around 1.02.0 mg per day from a reconstituted 20 mg vial
Culley, L., Hudson, N., Rapport, F., Katbamna, S., Johnson, M., Hui, L., & Bharadwaj, A
Impaired forelimb function scoring in rats that received cuprizone diet, and then cuprizone intragastrical applications, and thereby, cuprizone toxicity manifestations
Among those who felt they needed to self-medicate, the main reasons given were to improve fatigue and to reduce brain fog and pins and needles
Finish with a hydrating sheet mask or peptide cream and go to bed
The product should not be given intravenously